Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Will

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 30, 2020
Correction to: Assessing the impacts of having a child with achondroplasia on parent well-beingKathryn M Pfeiffer, Meryl Brod, Alden Smith, et al.
Clinical Pharmacology and Therapeutics|September 11, 2023
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic SteatohepatitisChih-Ming Leo Tseng, Kemal Balic, R Will Charlton, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 18, 2020
Assessing the impacts of having a child with achondroplasia on parent well-beingKathryn M Pfeiffer, Meryl Brod, Alden Smith, et al.
American Journal of Medical Genetics. Part A|October 21, 2020
Assessing physical symptoms, daily functioning, and well-being in children with achondroplasiaKathryn M Pfeiffer, Meryl Brod, Alden Smith, et al.
The EMBO Journal|September 22, 2001
Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriersR M Barron, V Thomson, E Jamieson, et al.
Journal of Bacteriology|September 25, 2002
The positive regulator, TraJ, of the Escherichia coli F plasmid is unstable in a cpxA* backgroundMichael J Gubbins, Isabella Lau, William R Will, et al.
British Journal of Clinical Pharmacology|April 28, 2022
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNPVibeke Miller Breinholt, Per Holse Mygind, Eva Dam Christoffersen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 10, 2023
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human VolunteersMoti Rosenstock, Leo Tseng, Andrew Pierce, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humansM R Scott, R Will, J Ironside, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 12, 2003
Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosisRaquel R Bartz, Robert B Love, Glen E Leverson, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 30, 2020
Correction to: Assessing the impacts of having a child with achondroplasia on parent well-beingKathryn M Pfeiffer, Meryl Brod, Alden Smith, et al.
Clinical Pharmacology and Therapeutics|September 11, 2023
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic SteatohepatitisChih-Ming Leo Tseng, Kemal Balic, R Will Charlton, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 18, 2020
Assessing the impacts of having a child with achondroplasia on parent well-beingKathryn M Pfeiffer, Meryl Brod, Alden Smith, et al.
American Journal of Medical Genetics. Part A|October 21, 2020
Assessing physical symptoms, daily functioning, and well-being in children with achondroplasiaKathryn M Pfeiffer, Meryl Brod, Alden Smith, et al.
The EMBO Journal|September 22, 2001
Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriersR M Barron, V Thomson, E Jamieson, et al.
Journal of Bacteriology|September 25, 2002
The positive regulator, TraJ, of the Escherichia coli F plasmid is unstable in a cpxA* backgroundMichael J Gubbins, Isabella Lau, William R Will, et al.
British Journal of Clinical Pharmacology|April 28, 2022
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNPVibeke Miller Breinholt, Per Holse Mygind, Eva Dam Christoffersen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 10, 2023
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human VolunteersMoti Rosenstock, Leo Tseng, Andrew Pierce, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humansM R Scott, R Will, J Ironside, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 12, 2003
Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosisRaquel R Bartz, Robert B Love, Glen E Leverson, et al.
Pageof 11